Colgate-Palmolive Company (NYSE:CL ) Consumer Analyst Group of New York Conference (CAGNY) 2025 February 21, 2025 8:00 AM ET Company Participants Noel Wallace - Chairman, President and Chief Executive Officer Prabha Narasimhan - Executive VP & GM of India Conference Call Participants Bryan Spillane - Bank of America Dara Mohsenian - Morgan Stanley Bryan Spillane Good morning. It's Friday, day four, day four and a half I guess here at CAGNY.
Colgate-Palmolive plans to expand its pet nutrition portfolio with the acquisition of Prime100, reinforcing its commitment to premium, science-backed pet food.
CL faces near-term headwinds. But its strong pricing strategy, premium innovation and brand-building investments lay the foundation for long-term growth.
Colgate-Palmolive stock (NYSE: CL) recently reported its Q4 results, with revenues missing and earnings slightly ahead of the street estimates. The company reported revenue of $4.94 billion and adjusted earnings of $0.91 per share, compared to the consensus estimates of $4.99 billion and $0.89, respectively.
Colgate-Palmolive Company CL posted mixed results for the fourth quarter on Friday.
Shares of Colgate-Palmolive (CL -4.61%) pulled back today after the household products giant missed the mark on the top line in its fourth-quarter earnings report and gave a weak outlook.
Goldman Sachs analyst Bonnie Herzog reiterated a Buy rating on the shares of Colgate-Palmolive Co CL with a price forecast of $106.
CL's Q4 results show continued gains from volume and pricing, leading to organic sales growth in five of the six divisions. Improved gross margins aid EPS growth.
Colgate-Palmolive (CL) shares fell 5% Friday after the household products company missed revenue forecasts and gave weak guidance as it was hurt by foreign exchange rates.
Toothpaste and manual toothbrushes market leader Colgate-Palmolive Company released its fourth quarter and full-year 2024 results today. Judging by the share price reaction, and considering CL stock is down more than 20% from its all-time high, this clearly looks like a “buy the dip” moment. However, I'll explain why I don't think it's a good idea to buy CL shares, either for dividend or total return investors, and despite the company's undoubtedly solid 2024 performance.
Colgate-Palmolive Company (NYSE:CL ) Q4 2024 Earnings Conference Call January 31, 2025 8:30 AM ET Company Participants John Faucher - Chief Investor Relations Officer and Executive Vice President, M&A Noel Wallace - Chairman, President and Chief Executive Officer Stanley Sutula - Chief Financial Officer Conference Call Participants Dara Mohsenian - Morgan Stanley Peter Grom - UBS Bonnie Herzog - Goldman Sachs Andrea Teixeira - JPMorgan Kaumil Gajrawala - Jefferies Kevin Grundy - BNP Bryan Spillane - Bank of America Olivia Tong - Raymond James Sergio Matsumoto - TD Cowen Christopher Carey - Wells Fargo Stephen Powers - Deutsche Bank Lauren Lieberman - Barclays Robert Ottenstein - Evercore ISI Korinne Wolfmeyer - Piper Sandler Mark Astrachan - Stifel Filippo Falorni - Citi Edward Lewis - Redburn Atlantic Operator Good morning. Welcome to today's Colgate-Palmolive 2024 Fourth Quarter and Year End Earnings Conference Call.
The headline numbers for Colgate-Palmolive (CL) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.